Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 30 member B (FAM30B, also known as HsT16028 or KIAA0125P1) is a gene entry with minimal functional characterization and no evidence to support its activity as a receptor, enzyme, transporter, or other defined therapeutic target class. FAM30B is listed in gene databases but has no established biological function, known disease association, or therapeutic relevance. No drugs or mechanisms of action are associated, and there are no known biomarker or safety concerns reported for this entity[5]. There is no evidence it is a therapeutic target—FAM30B appears to be a predicted or hypothetical protein without meaningful experimental or clinical data. If you are seeking information on a target for drug discovery or biomarker applications, FAM30B is not currently considered valid or actionable for such purposes[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 30 member B (FAM30B).